Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Shanghai Kou Qiang Yi Xue ; 28(1): 71-75, 2019 Feb.
Article in Chinese | MEDLINE | ID: mdl-31081004

ABSTRACT

PURPOSE: The aim of the present research was to evaluate the regeneration effect of injectable-platelet rich fibrin (I-PRF) in lateral sinus lift. METHODS: A total of 46 cases, who lost their single posterior tooth with residual bone height of 3-5 mm, who needed lateral sinus lift, were treated in our hospital for implantation from June 2014 to Jun 2015. They were randomly divided into 2 groups. In group A, Bio-oss was used as a sole grafting material to fill the sinus; in group B, Bio-oss was used in combination with I-PRF to fill the sinus. Cone-beam CT (CBCT) was taken preoperatively, the residual bone height (RBH) was measured. The new formed bone height (NFBH) was measured immediately, 6 months and 12 months after surgery. ISQ values of implants were taken 4 months, 6 months postoperatively. SPSS 20.0 software was used for statistical analysis. RESULTS: All cases achieved primary healing, no infection or dehiscence was found. No significant difference of the RBH and NFBH was found between pre-operation or 12 months postoperatively, while significant difference was found immediately and 6 months postoperatively. The value of ISQ in group A was significantly higher than that in group B at 4 months(P<0.05), and there was no significant difference between 2 groups 6 months after operation(P>0.05). CONCLUSIONS: I-PRF is a safe and reliable material in sinus lift, which can effectively shorten the healing time and enhance the effect of osteogenesis.


Subject(s)
Bone Regeneration , Platelet-Rich Fibrin , Sinus Floor Augmentation , Transverse Sinuses , Blood Platelets , Fibrin , Humans , Maxilla , Maxillary Sinus , Pilot Projects
2.
Shanghai Kou Qiang Yi Xue ; 25(1): 77-81, 2016 Feb.
Article in Chinese | MEDLINE | ID: mdl-27063314

ABSTRACT

PURPOSE: To observe the incidence, location, morphological characteristics of sinus septa among Changzhou population, and to investigate the relationship between maxillary posterior teeth loss and bony septum, and the guiding significance for sinus lift. METHODS: One hundred and twenty-four subjects were selected, the preoperative cone-beam CT (CBCT) data was analyzed by NNT software, which provided a three-dimensional measurement of the maxillary sinus septa. SPSS 13.0 software package was used for statistical analysis. RESULTS: 33.87%(42/124)subjects had sinus septa, 27.42%(68/248)sinus had septa. 66.18% (45/68) of the septa were located in the middle region, 22.06% (15/68)in the posterior region, 11.76%(8/68) in the anterior region. The occurrence of sinus septa had no relation with gender, age and loss of teeth. CONCLUSIONS: The sinus septa can be observed by CBCT for the position, pattern, to predict the difficulty of the surgery, and enhance the success rate.


Subject(s)
Cone-Beam Computed Tomography , Maxillary Sinus/diagnostic imaging , Tooth Loss/epidemiology , China/epidemiology , Humans , Maxilla , Software
3.
Zhonghua Liu Xing Bing Xue Za Zhi ; 24(3): 180-3, 2003 Mar.
Article in Chinese | MEDLINE | ID: mdl-12816706

ABSTRACT

OBJECTIVE: To explore the feasibility of replacement of ordinary syringes by auto-disposal syringes (AD) in China. METHODS: Sampling survey was conducted in Hebei province to collect data on the direct medical spending of hepatitis B and their Disability Adjusted Life Year (DALY) losses. The financial burden on hepatitis B was calculated based on the result of field survey as well as through data-base of the Second National Health Services Survey of MOH in 1998. The cost-benefit analysis was employed, in which the saving of the financial burden on hepatitis B patients attributing to unsafe injections was taken as the benefit of intervention and the increased expenditures of AD syringes as the costs. RESULTS: The total financial disease burden of Hepatitis B in China in 2001 was between RMB 16.19 and 20.17 billion Yuan and the financial disease burden per patient was between RMB 1755.38 and 1409.64 Yuan. Study on the cost-benefit analysis in the replacement intervention program showed high financial feasibility. The Benefit-Cost Ratio (BCR) of the measure was between 32.46 and 97.39, which was bigger in rural areas than that in cities. The direct BCR was less than one when the price gap between ordinary syringe and AD exceeded RMB 0.24 Yuan. CONCLUSION: The intervention of safe injection practice through universal usage of AD to replace ordinary syringe seemed to be applicable due to its high potential economic benefits.


Subject(s)
Cross Infection/etiology , Disposable Equipment/economics , Hepatitis B/transmission , Injections/instrumentation , China/epidemiology , Cost-Benefit Analysis , Cross Infection/economics , Cross Infection/prevention & control , Cross-Sectional Studies , Disposable Equipment/statistics & numerical data , Equipment Reuse/statistics & numerical data , Female , Hepatitis B/economics , Humans , Injections/adverse effects , Injections/economics , Male , Risk Factors , Sampling Studies , Surveys and Questionnaires , Syringes/economics
SELECTION OF CITATIONS
SEARCH DETAIL
...